Anaxomics maps have been presented in the cover page of the November issue of Nature Chemical Biology

Home > Business Cases > Rationale of action of new compounds in Nutraceuticals

Rationale of action of new compounds in Nutraceuticals


Business Case: Nutraceuticals Explanation
- 1 -
- 2 -
- 3 -
- 4 -
  • - 1 - Ketosis Seed Proteins
  • - 2 - Map Extension with interactomics technology and hand curated safety databases
  • - 3 - Transformation and analysis of the ketosis Map
  • - 4 - Identification of diabetes "hot spots" in the ketosis map. Diabetes identified as one of the conditions most related to ketosis by several map analysis

  • As a result of our strategy, a number of research articles have been published in relevant publications, like for example:

    NutraFoods 2010, 9: 31

    Jordi Naval, Judith Farrés

    Systems Biology footprint on the nutraceuticals and cosmetics arena

    "Systems Biology, a new and validated integrative technology, finds many uses in the fields of cosmetics and nutraceuticals, accelerating the design of new products, and providing scientific support for health claims"


    Nutr Metab, 2010, 7: 88

    Judith Farrés, Albert Pujol, Mireia Coma, Jose Luis Ruiz, Jordi Naval, Josè Manuel Mas, Agustì Molins, Joan Fondevila, Patrick Aloy

    Revealing the molecular relationship between type 2 diabetes and the metabolic changes induced by a very-low-carbohydrate low-fat ketogenic diet

    "A strong relationship between the insulin resistance pathway and the ketosis main pathway was identified, providing a possible explanation for the improvement observed in clinical trials"

    punto cuadradoPlease, contact us here to request more information.
    Anaxomics on LinkedIn